The Journal of Neuroscience, September 20, 2006, 26(38):9713-9721; doi:10.1523/JNEUROSCI.0734-06.2006
Previous Article | Next Article 
Development/Plasticity/Repair
Neurotrophin-3 Gradients Established by Lentiviral Gene Delivery Promote Short-Distance Axonal Bridging beyond Cellular Grafts in the Injured Spinal Cord
Laura Taylor,1
Leonard Jones,1
Mark H. Tuszynski,1,2 and
Armin Blesch1
1Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, and 2Veterans Administration Medical Center, San Diego, California 92165
Correspondence should be addressed to Dr. Armin Blesch, Department of Neurosciences-0626, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0626. Email: ablesch{at}ucsd.edu
Neurotrophic factor delivery to sites of spinal cord injury (SCI) promotes axon growth into but not beyond lesion sites. We tested the hypothesis that sustained growth factor gradients beyond regions of SCI will promote significant axonal bridging into and beyond lesions. Adult rats underwent C3 lesions to transect ascending dorsal column sensory axons, and autologous bone marrow stromal cells were grafted into the lesion to provide a cellular bridge for growth into the injured region. Concurrently, lentiviral vectors expressing neurotrophin-3 (NT-3) or green fluorescent protein (GFP) (controls) were injected into the host cord rostral to the lesion to promote axon extension beyond the graft/lesion. Four weeks later, NT-3 gradients beyond the lesion were detectable by ELISA in animals that received NT-3-expressing lentiviral vectors, with highest average NT-3 levels located near the rostral vector injection site. Significantly more ascending sensory axons extended into tissue rostral to the lesion site in animals injected with NT-3 vectors compared with GFP vectors, but only if the zone of NT-3 vector transduction extended continuously from the injection site to the graft; any "gap" in NT-3 expression from the graft to rostral tissue resulted in axon bridging failure. Despite axon bridging beyond the lesion, regenerating axons did not continue to grow over very long distances, even in the presence of a continuing growth factor gradient beyond the lesion. These findings indicate that a localized and continuous gradient of NT-3 can achieve axonal bridging beyond the glial scar, but growth for longer distances is not sustainable simply with a trophic stimulus.
Key words: NT-3; spinal cord injury; ascending sensory; gene therapy; lentivirus; regeneration
Received Feb. 17, 2006;
revised June 30, 2006;
accepted Aug. 3, 2006.
Correspondence should be addressed to Dr. Armin Blesch, Department of Neurosciences-0626, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0626. Email: ablesch{at}ucsd.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2006 26: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Hollis II, P. Jamshidi, K. Low, A. Blesch, and M. H. Tuszynski
Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation
PNAS,
April 28, 2009;
106(17):
7215 - 7220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hurtado, H. Podinin, M. Oudega, and B. Grimpe
Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord
Brain,
October 1, 2008;
131(10):
2596 - 2605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Blesch and M. H. Tuszynski
Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury
J. Neurosci.,
September 26, 2007;
27(39):
10535 - 10545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Q. Tang, P. Heron, C. Mashburn, and G. M. Smith
Targeting Sensory Axon Regeneration in Adult Spinal Cord
J. Neurosci.,
May 30, 2007;
27(22):
6068 - 6078.
[Abstract]
[Full Text]
[PDF]
|
 |
|